Beijing Bio-Targeting Therapeutics Technology Co., Ltd (BioTTT) is a biotech companydedicated to the discovery and development of innovative, best-in-class,targeted and immuno-oncology drugs that address severe unmet medical needs inthe field of cancer diagnosis and treatment. BioTTT was founded in September 2011 and is situated in Beijing economicand technological development zone-Huilongsen Science Park. Taking advantage ofthe great environment and the favorable policies of the government, BioTTT hasbuilt a laboratory compliant with the international standard certification ofGMP and GLP. A number of products with intellectual property protection arebeing actively investigated at various stages, including an in vitro diagnosiskit for circulating viable tumor cells and an innovative anti-cancer drug(BioTTT001). Other businesses are provision of CTC culture and services ofbiotechnologies.
The company strategy is to build an integrated biotech company that discovers, develops andcommercializes innovative diagnosis and therapy for cancer both independentlyand in collaboration with top academic institutions and other partners.
BioTTT has a highly motivated team focused on the successful execution of ourobjectives and strategy. We have also tapped the talents of a number ofworld-known overseas (UK, US, etc.) and domestic experts in the biotech andcancer research field. We are striving to develop and advance the innovativetherapies for patients who are battling with cancer.